VARITHENA
LIVE

Serial Number

79139582

Owner

Provensis Limited

Filing Date

Apr 16, 2013

Add to watchlist:

No watchlists yet
View on USPTO

VARITHENA Trademark

Serial Number: 79139582 • Registration: 4638965

VARITHENA is a trademark filed by Provensis Limited on April 16, 2013. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Provensis Limited (15 trademarks)

5 Fleet Place

Entity Type: 99

Trademark Details

Filing Date

April 16, 2013

Registration Date

November 18, 2014

Published for Opposition

September 2, 2014

Cancellation Date

April 17, 2023

Goods & Services

Pharmaceutical preparations in the form of foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams for use in producing foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams or for use in preparing foams, for sclerotherapy, phlebology, angiology and proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment or for treatment of varicose veins, or arterio-venous malformations

Chemicals for use in the manufacture of pharmaceuticals for the treatment of angiologic disorders, particularly varicose veins; chemicals for use in the manufacture of injectable foams

Medical services for diagnosis in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; medical evaluation of diseases or disorders in the fields of sclerotherapy, phlebology, angiology and proctology, varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; medical treatment of diseases or disorders in the fields of sclerotherapy, phlebology, angiology and proctology, varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; medical services provided to post-treatment and homecare patients in the fields of sclerotherapy, phlebology, angiology, varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; providing outpatient medical services regarding the administering of medications and therapy in the fields of sclerotherapy, phlebology, angiology, varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment

Needles for medical use, namely, cannula needles; medical tubing for sclerotherapy; medical tubing for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles * none of the aforementioned goods being supportive bandages or compression bandages *; surgical and medical apparatus for producing and administering foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles * none of the aforementioned goods being supportive bandages or compression bandages *; surgical and medical apparatus for producing and administering sclerosing foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles * none of the aforementioned goods being supportive bandages or compression bandages *; surgical or medical apparatus for producing and administering foams for use in sclerotherapy, phlebology, angiology or proctology; syringes for producing and administering foams for use in sclerotherapy, phlebology, angiology or proctology; surgical and medical apparatus for administering and producing foams for use in sterilisation treatment; surgical and medical apparatus for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles * none of the aforementioned goods being supportive bandages or compression bandages *; syringes for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles * none of the aforementioned goods being supportive bandages or compression bandages *; devices for assessing the physical characteristics of such foams; medical devices for intravenous administration of sclerosing foam for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles * none of the aforementioned goods being supportive bandages or compression bandages *; medical devices for monitoring the position and effect of foam in the human body; medical diagnostic apparatus for diagnosing all the above medical conditions

Scientific research services related to sclerotherapy of veins, namely scientific research relating to provision of medical treatment in the fields of phlebology, proctology and angiology

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Nov 20, 2023 DENC
DEATH OF INTERNATIONAL REGISTRATION
Nov 20, 2023 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Jul 17, 2022 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jun 3, 2022 INTS
INVALIDATION PROCESSED
Jun 3, 2022 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 4, 2022 INTR
NEW REPRESENTATIVE AT IB RECEIVED
Jan 8, 2022 NREP
CANCELLED SECTION 71
Jun 4, 2021 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Oct 13, 2017 NREP
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Feb 17, 2016 INNA
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Dec 22, 2015 CORR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Dec 4, 2015 INPR
CORRECTION TRANSACTION RECEIVED FROM IB
Nov 7, 2015 CRCV
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 11, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 23, 2015 FICS
FINAL DISPOSITION PROCESSED
Jun 23, 2015 FIMP
CORRECTION UNDER SECTION 7 - PROCESSED
Apr 4, 2015 COC.
ASSIGNED TO PARALEGAL
Apr 4, 2015 PLGL
LIMITATION FROM THE IB EXAMINED AND ENTERED
Apr 2, 2015 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Mar 27, 2015 LIMG
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 18, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 18, 2014 R.PR
PUBLISHED FOR OPPOSITION
Sep 2, 2014 PUBO
NOTIFICATION PROCESSED BY IB
Aug 29, 2014 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 13, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 13, 2014 OP2R
NOTICE OF PUBLICATION
Aug 13, 2014 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 25, 2014 PREV
ASSIGNED TO LIE
Jul 24, 2014 ALIE
EXAMINERS AMENDMENT MAILED
Jul 11, 2014 CNEA
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 10, 2014 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 10, 2014 XAEC
EXAMINERS AMENDMENT -WRITTEN
Jul 10, 2014 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 18, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 18, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 18, 2014 TROA
REFUSAL PROCESSED BY IB
Jan 6, 2014 RFNT
APPLICATION FILING RECEIPT MAILED
Dec 20, 2013 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 19, 2013 RFCS
REFUSAL PROCESSED BY MPU
Dec 19, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 19, 2013 RFCR
NON-FINAL ACTION WRITTEN
Dec 18, 2013 CNRT
ASSIGNED TO EXAMINER
Dec 16, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 16, 2013 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 13, 2013 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 12, 2013 REPR